Long-term use of hormone therapy for urogenital complaints: is there a role?
In the past 20 years, menopause has become a household word, with much better understanding of its consequences. The growing numbers of menopausal women and clinical trials have coincided to draw increasing attention to the perimenopausal and menopausal years. Better studies of older therapies and the expanded number of new choices today, with more in development and evaluation, have complicated provider and patient choices, but greatly improved the potential for effective intervention.
Hendrix
Susan L
SL
Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Hutzel Women's Hospital, 4707 St. Antoine, Detroit, MI 48201, USA. shendrix@med.wayne.edu
D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D005836:Genitalia, Female / Q000187:drug effects*; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D011372:Progestins / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D014481:United States; D014549:Urinary Incontinence / Q000188:drug therapy; D014551:Urinary Tract / Q000187:drug effects*; D016387:Women's Health
D004967:Estrogens; D011372:Progestins